Abstract
The therapeutic effect of botulinum toxin in headache was observed coincidentally. The rationale for this new indication initially met with a great deal of scepticism, because the toxin's mechanism of action, cholinergic chemodenervation, does not fit the pathophysiological concept of migraine and other forms of headache. Meanwhile a fair number of studies have been published which indicate efficacy for botulinum toxin and recommend its use for the treatment of tension headache and migraine. According to the evidence-based medicine criteria, grade I evidence has been demonstrated. In addition the use of botulinum toxin for cluster-headache and secondary headache is discussed.
Further large scale studies will be regarded to demonstrate the long-term efficacy.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Göbel, H., Heinze, A., Heinze-Kuhn, K. et al. Evidence-based medicine: botulinum toxin A in migraine and tension-type headache. J Neurol 248 (Suppl 1), I34–I38 (2001). https://doi.org/10.1007/PL00007818
Issue Date:
DOI: https://doi.org/10.1007/PL00007818